PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding PAVmed Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 26 | −38 |
| SharesConverted for a 1-for-15 split | 830.6K | 149.6K | 753.7K | +72.7K (+10.7%) |
| Value | $3.67M | $661.2K | $3.10M | +$98.4K (+3.3%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held PAVmed Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 22,561 | $93.0K | 0.00% |
| Rockbridge Investment Management, LCC | 27 | $112 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1 | $4 | 0.00% |
Sold out (41)
Institutions that held PAVmed Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Not filed for Q4 2023 yet (1)
Institutions that held PAVmed Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Ayrton Capital LLC | 2,244,235 | $661.2K |